Date: June 3-5, 2004
Location: New Orleans, LA
The content presented here was prepared by independent authors under the editorial supervision of OncoEd and is not endorsed or sanctioned by the 40th Annual Meeting of the American Society of Clinical Oncology.
Conference Summaries
Advances in the Management of Colorectal Cancer: Proceedings from ASCO 2004
Leonard Saltz, MD, Memorial Sloan-Kettering Cancer Center
Chemotherapy-Induced Nausea and Vomiting (CINV): An Update from ASCO 2004
David Ettinger, MD Professor of Oncology and Medicine, Associate Director for Clinical Research in the Oncology Center, Johns Hopkins
New Developments in Anemia Treatment: ASCO 2004
Lee Schwartzberg, M.D., F.A.C.P., The West Clinic
Melanoma Update from ASCO 2004
Janice Cormier, MD, MD Anderson Cancer Center
Ovarian Cancer: Highlights from ASCO 2004
Douglas A. Levine, MD, Memorial Sloan-Kettering Cancer Center
ASCO 2004 Breast Cancer Report
Lee Schwartzberg, MD, FACP, The West Clinic
Prostate Cancer at the 2004 Annual Meeting of the American Society for Clinical Oncology (ASCO)
Tomasz M. Beer, MD, Associate Professor of Medicine, Oregon Health & Science University
Adjuvant Chemotherapy for Early Stage NSCLC: Evidence Presented at ASCO 2004 Provides Validation for a New Standard
Chandra P. Belani, MD and Suresh Ramalingam, University of Pittsburgh Cancer Institute
Locally Advanced NSCLC: Are We Making Progress
Chandra P. Belani, MD and Suresh Ramalingam, University of Pittsburgh Cancer Institute
Targeted Therapy for Non-Small Cell Lung Cancer: An Update
Chandra P. Belani, MD, and Sakkaraiappan Ramalingam, MD, University of Pittsburgh Cancer Institute